摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-ethyl-8-methylquinoline | 19209-58-6

中文名称
——
中文别名
——
英文名称
2-ethyl-8-methylquinoline
英文别名
2-ethyl-8-methyl-quinoline;2-Aethyl-8-methylchinolin;8-Methyl-2-ethylquinoline
2-ethyl-8-methylquinoline化学式
CAS
19209-58-6
化学式
C12H13N
mdl
MFCD18448810
分子量
171.242
InChiKey
PVTAJNPNIXPKLW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    270.2±9.0 °C(predicted)
  • 密度:
    1.032±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    12.9
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-ethyl-8-methylquinoline 在 copper(II) choride dihydrate 、 氧气氯乙酸乙酯 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 24.0h, 以52%的产率得到1-(8-methylquinolin-2-yl)ethan-1-one
    参考文献:
    名称:
    铜催化下氯乙酸盐促进的杂苄基亚甲基选择性氧化
    摘要:
    以氯乙酸乙酯为促进剂,实现了对CH键与分子氧和铜催化剂的高效选择性氧化和官能化反应,以制备相应的酮。在这种转化中,各种取代的N杂环化合物具有良好的耐受性。初步的机械研究表明,有机自由基物种参与了整个过程。N杂环化合物和氯乙酸乙酯相互协同作用,以激活亚甲基中的CH键,这导致自由基中间体的容易生成,从而导致相应的酮收率高。
    DOI:
    10.1002/anie.201409580
  • 作为产物:
    描述:
    1-戊烯-3-醇邻甲苯胺乙酸酐 、 silver hexafluoroantimonate 、 [RhCl2(p-cymene)]2 、 copper(II) acetate monohydrate 作用下, 以 四氢呋喃 为溶剂, 以62%的产率得到2-ethyl-8-methylquinoline
    参考文献:
    名称:
    钌催化的烯丙基醇苯胺的正式[3 + 3]环空中的无痕导向组策略:一种合成喹啉的单锅多米诺方法
    摘要:
    据报道,在取代喹啉的合成中,独特的钌催化的[3 + 3]苯胺与烯丙醇的环化反应。该方法在近端C–H键活化中采用了无痕导向组策略,代表了由苯胺一锅多米诺合成喹啉。
    DOI:
    10.1021/acs.orglett.7b00715
点击查看最新优质反应信息

文献信息

  • [EN] BINDING FUNCTION3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE<br/>[FR] COMPOSÉS DE SITE DE (BF3) AYANT UNE FONCTION 3 DE LIAISON UTILISÉS EN TANT QU'AGENTS THÉRAPEUTIQUES ET LEURS PROCÉDÉS D'UTILISATION
    申请人:UNIV BRITISH COLUMBIA
    公开号:WO2015154169A1
    公开(公告)日:2015-10-15
    This invention provides compound having a structure of Formulas: Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provide.
    这项发明提供了具有以下结构的化合物:这些化合物的用途包括治疗各种症状,包括前列腺癌,还提供了涉及这些化合物的治疗方法。
  • BISPIDINE DERIVATIVES AND THE USE THEREOF
    申请人:Helmholtz-Zentrum Dresden - Rossendorf e.V.
    公开号:EP4019051A1
    公开(公告)日:2022-06-29
    The invention relates to a compound of general formula I in which X is selected from consisting of a first group, a second group or a third group, wherein the first group consists of the second group consists of and the third group consists of Y is a group of general formula II or of general formula III if X is selected from the first group, Z is selected from a first group consisting of if X is selected from the second group, Z is selected from a second group consisting of if X is selected from the third group, Z is selected from a third group consisting of R1 and R2 independently are selected from the group consisting of a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C1-C6 heteroalkyl group, -C(O)-O-Ra, -C(O)-NRbRc, -C(O)-C(Ra)2-NRbRc, and -C(O)-NRb-(CH2)n-C(O)-O-Ra, wherein Ra, Rb and Rc each independently are selected from the group consisting of hydrogen, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C1-C6 heteroalkyl group, a substituted or unsubstituted aryl group and a group L and n is an integer from 1 to 10; R3 is selected from the group consisting of oxygen, sulfur, =NRd, and =CHRd, wherein Rd is selected from the group consisting of hydrogen, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C1-C6 heteroalkyl group, a substituted or unsubstituted aryl group, -O-Re, -C(O)-O-Re, -C(O)-NRfRg, and a group L, Re is hydrogen or a substituted or unsubstituted C1-C6 alkyl group, and Rf and Rg each independently are hydrogen or a substituted or unsubstituted C1-C6 alkyl group; and R4 is selected from the group consisting of -ORh, -SRh, -NHRh and -CH2Rh, wherein Rh is selected from the group consisting of hydrogen, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C1-C6 alkenyl group, a substituted or unsubstituted C1-C6 alkynyl group, a substituted or unsubstituted C1-C6 heteroalkyl group, a substituted or unsubstituted aryl group, -C(O)-(CH2)m-Rk, -C(O)-(CH2)m-NRmRn, a group -A-L and a group L, Rk is selected from the group consisting of a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C1-C6 heteroalkyl group, a substituted or unsubstituted aryl group, and a substituted or unsubstituted carboxy group, Rm and Rn each independently are hydrogen or a substituted or unsubstituted C1-C6 alkyl group, and m is 0 or an integer from 1 to 10; R5 and R6 independently are selected from the group consisting of hydrogen, chloro, bromo, iodo, and O-Ro, wherein R° is a substituted or unsubstituted C1-C6 alkyl group; A is a linker group and L is an amino acid residue or a peptide.
    本发明涉及通式 I 的化合物 其中 X 选自第一基团、第二基团或第三基团,其中第一基团包括 第二基团包括 第三组包括 Y 是通式 II 或通式 III 的基团 如果 X 选自第一组,则 Z 选自由以下物质组成的第一组 如果 X 选自第二组,则 Z 选自由以下各项组成的第二组 如果 X 选自第三组,则 Z 选自由以下各项组成的第三组 R1和R2各自独立地选自由取代或未取代的C1-C6烷基、取代或未取代的C1-C6杂烷基、-C(O)-O-Ra、-C(O)-NRbRc、-C(O)-C(Ra)2-NRbRc和-C(O)-NRb-(CH2)n-C(O)-O-Ra组成的组,其中Ra、Rb和Rc各自独立地选自氢、取代或未取代的C1-C6烷基、取代或未取代的C1-C6杂烷基、取代或未取代的芳基和基团L组成的组,且n为1至10的整数; R3 选自由氧、硫、=NRd 和=CHRd 组成的组,其中 Rd 选自由氢、取代或未取代的 C1-C6 烷基、取代或未取代的 C1-C6 杂烷基组成的组、取代或未取代的芳基、-O-Re、-C(O)-O-Re、-C(O)-NRfRg 和基团 L,Re 为氢或取代或未取代的 C1-C6 烷基,Rf 和 Rg 各自独立地为氢或取代或未取代的 C1-C6 烷基;和 R4选自由-ORh、-SRh、-NHRh和-CH2Rh组成的组,其中Rh选自由氢、取代或未取代的C1-C6烷基、取代或未取代的C1-C6烯基、取代或未取代的C1-C6炔基、取代或未取代的C1-C6杂烷基、取代或未取代的芳基、-C(O)-(CH2)m-Rk组成的组、-C(O)-(CH2)m-NRmRn、基团 -A-L 和基团 L,Rk 选自取代或未取代的 C1-C6 烷基、取代或未取代的 C1-C6 杂烷基、取代或未取代的芳基和取代或未取代的羧基组成的组,Rm 和 Rn 各自独立地为氢或取代或未取代的 C1-C6 烷基,m 为 0 或 1-10 的整数; R5和R6各自独立地选自氢、氯、溴、碘和O-Ro组成的组,其中R°是取代或未取代的C1-C6烷基; A 是连接基团 L 是氨基酸残基或肽。
  • Novel Carboxylic Acid Compounds Useful for Inhibiting Microsomal Prostaglandin E2 Synthase-1
    申请人:Eli Lilly and Company
    公开号:US20170313679A1
    公开(公告)日:2017-11-02
    The present invention provides compounds of Formula 1, or a pharmaceutically acceptable salts, thereof, where R, X, A, E, and G are as described herein, methods of preparing the compounds, and use of the compounds to treat pain and/or inflammation.
  • Chloroacetate-Promoted Selective Oxidation of Heterobenzylic Methylenes under Copper Catalysis
    作者:Jianming Liu、Xin Zhang、Hong Yi、Chao Liu、Ren Liu、Heng Zhang、Kelei Zhuo、Aiwen Lei
    DOI:10.1002/anie.201409580
    日期:2015.1.19
    The efficient selective oxidation and functionalization of CH bonds with molecular oxygen and a copper catalyst to prepare the corresponding ketones was achieved with ethyl chloroacetate as a promoter. In this transformation, various substituted N‐heterocyclic compounds were well tolerated. Preliminary mechanistic investigations indicated that organic radical species were involved in the overall process
    以氯乙酸乙酯为促进剂,实现了对CH键与分子氧和铜催化剂的高效选择性氧化和官能化反应,以制备相应的酮。在这种转化中,各种取代的N杂环化合物具有良好的耐受性。初步的机械研究表明,有机自由基物种参与了整个过程。N杂环化合物和氯乙酸乙酯相互协同作用,以激活亚甲基中的CH键,这导致自由基中间体的容易生成,从而导致相应的酮收率高。
  • Traceless Directing-Group Strategy in the Ru-Catalyzed, Formal [3 + 3] Annulation of Anilines with Allyl Alcohols: A One-Pot, Domino Approach for the Synthesis of Quinolines
    作者:Gangam Srikanth Kumar、Pravin Kumar、Manmohan Kapur
    DOI:10.1021/acs.orglett.7b00715
    日期:2017.5.19
    A unique, ruthenium-catalyzed, [3 + 3] annulation of anilines with allyl alcohols in the synthesis of substituted quinolines is reported. The method employs a traceless directing group strategy in the proximal C–H bond activation and represents a one-pot Domino synthesis of quinolines from anilines.
    据报道,在取代喹啉的合成中,独特的钌催化的[3 + 3]苯胺与烯丙醇的环化反应。该方法在近端C–H键活化中采用了无痕导向组策略,代表了由苯胺一锅多米诺合成喹啉。
查看更多